Identification of anti-syntaxin 5 autoantibody as a novel serum marker of endometriosis

Journal of Reproductive Immunology

Volumn 91, Issue 1-2, 2011, Pages 48-55

  Nabeta, Motowo ^a   Abe, Yasuhito ^a   Takaoka, Yuki ^a   Kusanagi, Yasuki ^a,b   Ito, Masaharu ^a  

^a EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b EHIME PREFECTURAL UNIVERSITY OF HEALTH SCIENCES   (Japan)

Author keywords

ELISA; Endometriosis; Serum; Syntaxin 5

Indexed keywords

AUTOANTIBODY; BIOLOGICAL MARKER; RECOMBINANT PROTEIN; SYNTAXIN; SYNTAXIN 5 ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ENDOMETRIOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROBLAST; GEL ELECTROPHORESIS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY; WESTERN BLOTTING;

ADOLESCENT; ADULT; AUTOANTIBODIES; BIOLOGICAL MARKERS; CELL LINE; ENDOMETRIOSIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MIDDLE AGED; QA-SNARE PROTEINS; SENSITIVITY AND SPECIFICITY;

EID: 80052414816     PISSN: 01650378     EISSN: 18727603     Source Type: Journal    
DOI: 10.1016/j.jri.2011.04.012     Document Type: Article

References (22)

1. Abe Y., Matsumoto S., Kito K., Ueda N. Cloning and expression of a novel MAPKK-like protein kinase, lymphokine-activated killer t-cell-originated protein kinase, specifically expressed in the testis and activated lymphoid cells. J. Biol. Chem. 2000, 275:21525-21531.
2. American Fertility Society Revised American Society for Reproductive Medicine classification of endometriosis: 1996. Fertil. Steril. 1997, 67:817-821.
3. Bedaiwy M., Falcone T. Laboratory testing for endometriosis. Clin. Chim. Acta 2004, 340:41-56.
4. Bulun S. Endometriosis. N. Engl. J. Med. 2009, 360:268-279.
5. Check J., Check M.L., Kiefer D., Aikins J. Ovarian cancer in a woman previously diagnosed with endometriosis and an extremely high serum CA-125 level. Clin. Exp. Obstet. Gynecol. 2001, 28:83-85.
6. Cramer D., Missmer S. The epidemiology of endometriosis. Ann. N. Y. Acad. Sci. 2002, 955:11-22.
7. Ghaemmaghami F., Karimi Zarchi M., Hamedi B. High levels of ca125 (over 1000U/ml) in patients with gynecologic disease and no malignant conditions: three cases and literature review. Arch. Gynecol. Obstet. 2007, 276:559-561.
8. Gitlits V., Toh B.H., Sentry J.W. Disease association, origin, and clinical relevance of autoantibodies to the glycolytic enzyme enolase. J. Invest. Med. 2001, 49:138-145.
9. Gorai I., Ishikawa M., Onose R., Hirahara F., Minaguchi H. Antiendometrial autoantibodies are generated in patients with endometriosis. Am. J. Reprod. Immunol. 1993, 29:116-123.
10. Inagaki J., Sugiura-Ogasawara M., Nomizu M., Nakatsuka M., Ikuta K., Suzuki N., Kaihara K., Kobayashi K., Yasuda T., Shoenfeld Y., Aoki K., Matsuura E. An association of IgG anti-laminin-1 autoantibodies with endometriosis in infertile patients. Hum. Reprod. 2003, 18:544-549.
11. Kashyap R. Extremely elevated serum CA125 due to endometriosis. Aust. N. Z. J. Ostet. Gynaecol. 1999, 39:269-270.
12. Marchino G., Gennarelli G., Enria R., Bongioanni F., Lipari G., Massobrio M. Diagnosis of pelvic endometriosis with use of macroscopic versus histologic findings. Fertil. Steril. 2005, 84:12-15.
13. Matarese G., De Placido G., Nikas Y., Alviggi C. Pathogenesis of endometriosis: natural immunity dysfunction or autoimmune disease?. Trends Mol. Med. 2003, 9:223-228.
14. Mathur S., Peress M.R., Williamson H.O., Youmans C.D., Maney S.A., Garvin A.J., Rust P.F., Fudenberg H.H. Autoimmunity to endometrium and ovary in endometriosis. Clin. Exp. Immunol. 1982, 50:259-266.
15. Practice Committee of American Society for Reproductive Medicine Treatment of pelvic pain associated with endometriosis. Fertil. Steril. 2008, 90:S260-S269.
16. Murase R., Abe Y., Takeuchi T., Nabeta M., Imai Y., Kamei Y., Kagawa-Miki L., Ueda N., Sumida T., Hamakawa H., Kito K. Serum autoantibody to sideroflexin 3 as a novel tumor marker for oral squamous cell carcinoma. Proteomics Clin. Appl. 2008, 2:517-527.
17. Nabeta M., Abe Y., Kagawa L., Haraguchi R., Kito K., Ueda N., Sugita A., Yokoyama M., Kusanagi Y., Ito M. Identification of anti-α-enolase autoantibody as a novel serum marker for endometriosis. Proteomics Clin. Appl. 2009, 3:1201-1210.
18. Nabeta M., Abe Y., Haraguchi R., Kito K., Kusanagi Y., Ito M. Serum anti-PDIK1L autoantibody as a novel marker for endometriosis. Fert. Steril. 2010, 94. 2552-2557.e1.
19. Ozkan S., Murk W., Arici A. Endometriosis and infertility: epidemiology and evidence-based treatments. Ann. N. Y. Acad. Sci. 2008, 1127:92-100.
20. Rosa E.Silva A., Rosa E.Silva J.C., Ferriani R.A. Serum CA-125 in the diagnosis of endometriosis. Int. J. Gynaecol. Obstet. 2007, 96:206-207.
21. Simoens S., Hummelshoj L., D'Hooghe T. Endometriosis: cost estimates and methodological perspective. Hum. Reprod. Update 2007, 13:395-404.
22. Somigliana E., Viganò P., Tirelli A.S., Felicetta I., Torresani E., Vignali M., Di Blasio A.M. Use of the concomitant serum dosage of CA 125 CA 19-9 and interleukin-6 to detect the presence of endometriosis. Results from a series of reproductive age women undergoing laparoscopic surgery for benign gynaecological conditions. Hum. Reprod. 2004, 19:1871-1876.